Nano-Targeted Delivery of Rad6/Translesion Synthesis Inhibitor for Triple Negative Breast Cancer Therapy
Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-18-0364
Full Text
Open PDFAbstract
Available in full text
Date
September 21, 2018
Authors
Publisher
American Association for Cancer Research (AACR)